GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Net Margin %

BioVaxys Technology (BioVaxys Technology) Net Margin % : 0.00% (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. BioVaxys Technology's Net Income for the three months ended in Jul. 2023 was $-1.19 Mil. BioVaxys Technology's Revenue for the three months ended in Jul. 2023 was $0.00 Mil. Therefore, BioVaxys Technology's net margin for the quarter that ended in Jul. 2023 was 0.00%.

The historical rank and industry rank for BioVaxys Technology's Net Margin % or its related term are showing as below:


BVAXF's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.15
* Ranked among companies with meaningful Net Margin % only.

BioVaxys Technology Net Margin % Historical Data

The historical data trend for BioVaxys Technology's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Net Margin % Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Net Margin %
- - - - -

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioVaxys Technology's Net Margin %

For the Biotechnology subindustry, BioVaxys Technology's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioVaxys Technology's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Net Margin % distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Net Margin % falls into.



BioVaxys Technology Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BioVaxys Technology's Net Margin for the fiscal year that ended in Oct. 2022 is calculated as

Net Margin=Net Income (A: Oct. 2022 )/Revenue (A: Oct. 2022 )
=-8.567/0
= %

BioVaxys Technology's Net Margin for the quarter that ended in Jul. 2023 is calculated as

Net Margin=Net Income (Q: Jul. 2023 )/Revenue (Q: Jul. 2023 )
=-1.192/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology  (OTCPK:BVAXF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


BioVaxys Technology Net Margin % Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.